what specific molecular pathways or immune cell subsets should researchers prioritize using flow cytometry to provide clinicians with a truly actionable, targeted immune signature of the patient?

it is a specific question that can help thousands for clinicians and lab experts to find targeted biomarkers that can achieve to diagnose and see a result for their therapies by blocking molecular pathways that can find the biochemical, environmental tumor microenvironment,  multiplication, resistance of the tumor and many others and will help to block all mechanisms of the carcinogenesis